无法导入 JabRef 3.0

无法导入 JabRef 3.0

我无法将 RIS 和 BIB 文件导入我的 JabRef 数据库或新数据库。当我尝试导入 RIS 文件时,我收到消息“文件格式错误”。如果我尝试使用拖放操作,我会收到“找不到合适的导入格式”的消息。我知道这些文件没有问题,因为我之前将这些特定文件导入旧版本 (2.8) 的 JabRef,并且运行良好。如果我尝试打开 BIB 文件,它会打开一个文件但不显示任何条目。

这是什么原因造成的?我该如何解决?由于这些原因,目前我无法与 JabRef 合作。

示例 RIS 文件

TY  - JOUR
M1  - Copyright (C) 2016 American Chemical Society (ACS). All Rights Reserved.
N1  - CAPLUS AN 2012:446586(Journal; Online Computer File)
PY  - 2012///
PB  - Elsevier B.V.
DO  - 10.1016/j.powtec.2012.01.008
M3  - 10.1016/j.powtec.2012.01.008
AU  - Salustio, P. J.
AU  - Feio, G.
AU  - Figueirinhas, J. L.
AU  - Cabral-Marques, H. M.
AU  - Costa, P. C.
AU  - Pinto, J. F.
T1  - Release profile of ibuprofen in β-cyclodextrin complexes from two different solid dosage forms.
N2  - The objective of this work was to develop solid dosage forms using powders contg. inclusion complexes (ibuprofen with β-cyclodextrin) which were used to produce tablets (direct compression without addnl. excipients) and pellets (extrusion/spheronization) from wet mass contg. 40% (wt./wt.) of microcryst. cellulose.  The pellets also demonstrated that during prepn. of the wet mass, the inclusion process occurred in a same yield that when pre-complexation was used.  The particles characteristics were evaluated after being obtained through different complexation methods.  The results showed that the tensile strength and profile dissoln. were as expected for both dosage forms.  Tablets contg. inclusion complexes showed higher soly. when compared with a ref. formulation and with two com. formulations.  The ibuprofen released from the two pellets formulations didn't show relevant differences between them.  The drug released was analyzed considering different dissoln. parameters.  The advantages of these new methodologies can be summarized as: (a) tablets were produced at a lower cost for the total process; and (b) in the pellet's prepn. there was no need of the previous complexation method resulting in a decrease in time and energy required. [on SciFinder(R)]
JA  - Powder Technol.
JF  - Powder Technology
VL  - 221
SP  - 245
EP  - 251
SN  - 0032-5910
KW  - ibuprofen beta cyclodextrin inclusion complex tablet
ER  - 

顺便说一句,我使用的是 Windows 7 64 位。也许这可能是原因之一?如果可能的话,我想避免升级,因为我没有计算机的管理权限,我需要请管理员来执行此操作。我该如何提供上述 RIS?以下是其内容:

TY  - JOUR
M1  - Copyright (C) 2016 American Chemical Society (ACS). All Rights Reserved.
N1  - CAPLUS AN 2012:446586(Journal; Online Computer File)
PY  - 2012///
PB  - Elsevier B.V.
DO  - 10.1016/j.powtec.2012.01.008
M3  - 10.1016/j.powtec.2012.01.008
AU  - Salustio, P. J.
AU  - Feio, G.
AU  - Figueirinhas, J. L.
AU  - Cabral-Marques, H. M.
AU  - Costa, P. C.
AU  - Pinto, J. F.
T1  - Release profile of ibuprofen in β-cyclodextrin complexes from two different solid dosage forms.
N2  - The objective of this work was to develop solid dosage forms using powders contg. inclusion complexes (ibuprofen with β-cyclodextrin) which were used to produce tablets (direct compression without addnl. excipients) and pellets (extrusion/spheronization) from wet mass contg. 40% (wt./wt.) of microcryst. cellulose.  The pellets also demonstrated that during prepn. of the wet mass, the inclusion process occurred in a same yield that when pre-complexation was used.  The particles characteristics were evaluated after being obtained through different complexation methods.  The results showed that the tensile strength and profile dissoln. were as expected for both dosage forms.  Tablets contg. inclusion complexes showed higher soly. when compared with a ref. formulation and with two com. formulations.  The ibuprofen released from the two pellets formulations didn't show relevant differences between them.  The drug released was analyzed considering different dissoln. parameters.  The advantages of these new methodologies can be summarized as: (a) tablets were produced at a lower cost for the total process; and (b) in the pellet's prepn. there was no need of the previous complexation method resulting in a decrease in time and energy required. [on SciFinder(R)]
JA  - Powder Technol.
JF  - Powder Technology
VL  - 221
SP  - 245
EP  - 251
SN  - 0032-5910
KW  - ibuprofen beta cyclodextrin inclusion complex tablet
ER  - 


TY  - JOUR
M1  - Copyright (C) 2016  U.S. National Library of Medicine.
N1  - MEDLINE AN 2009142766((COMPARATIVE STUDY); Journal; Article; (JOURNAL ARTICLE))
PY  - 2009///
SN  - 1873-3441
AU  - Salustio, P. J.
AU  - Feio, G.
AU  - Figueirinhas, J. L.
AU  - Pinto, J. F.
AU  - Cabral, Marques H. M.
T1  - The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity
N2  - The work aims to prove the complexation of two model drugs (ibuprofen, IB and indomethacin, IN) by beta-cyclodextrin (betaCD), and the effect of water in such a process, and makes a comparison of their complexation yields.  Two methods were considered: kneading of a binary mixture of the drug, betaCD, and inclusion of either IB or IN in aqueous solutions of betaCD.  In the latter method water was removed by air stream, spray-drying and freeze-drying.  To prove the formation of complexes in final products, optical microscopy, UV spectroscopy, IR spectroscopy, DSC, X-ray and NMR were considered.  Each powder was added to an acidic solution (pH=2) to quantify the concentration of the drug inside betaCD cavity.  Other media (pH=5 and 7) were used to prove the existence of drug not complexed in each powder, as the drugs solubility increases with the pH.  It was observed that complexation occurred in all powders, and that the fraction of drug inside the betaCD did not depend neither on the method of complexation nor on the processes of drying considered.[on SciFinder (R)]
JA  - Eur J Pharm Biopharm
JF  - European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
VL  - 71
IS  - 2
SP  - 377
EP  - 86
ER  - 

2016 年 1 月 25 日更新 我在家里的 Windows 7(32 位)上安装了相同的版本,它能够导入 RIS 文件。我还在出现上述问题的计算机(Wndows 7,64 位)上尝试了 JabRef-3.2.JAR 文件,但这个版本也无法导入 RIS 文件。这可能是一个错误吗?


2016 年 1 月 27 日更新 我尝试使用 JabRef-2.11.1.Jar。只有当语言设置为英语并且编码设置为 ASCII 时,它才能导入 RIS 文件。使用其他结束符会导致相同的错误。但是,此技巧无法解决 JabRef-3.2.JAR 或已安装的 3.0 的问题

答案1

我使用 JabRef 3.2 时效果很好(我还没有测试过早期版本)。

我将您的示例保存在文件名 test.RIS 中,然后:

  • “文件 -> 导入到新数据库”。

    弹出一个标题为“打开”的窗口。

  • 选择文件:test.RIS
  • 过滤器的选择:RIS
  • 单击“确定”

    完毕

相关内容